|
1
|
Mathur P, Sathishkumar K, Chaturvedi M,
Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan
S and Roselind FS: ICMR-NCDIR-NCRP Investigator Group: Cancer
statistics, 2020: Report from national cancer registry programme,
India. JCO Glob Oncol. 6:1063–1075. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malvia S, Bagadi SA, Dubey US and Saxena
S: Epidemiology of breast cancer in Indian women. Asia Pac J Clin
Oncol. 13:289–295. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mehrotra R and Yadav K: Breast cancer in
India: Present scenario and the challenges ahead. World J Clin
Oncol. 13:209–218. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chakraborty S and Rahman T: The
difficulties in cancer treatment. Ecancermedicalscience.
6:ed162012.PubMed/NCBI
|
|
5
|
Tentler JJ, Tan AC, Weekes CD, Jimeno A,
Leong S, Pitts TM, Arcaroli JJ, Messersmith WA and Eckhardt SG:
Patient-derived tumour xenografts as models for oncology drug
development. Nat Rev Clin Oncol. 9:338–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gillet JP, Calcagno AM, Varma S, Marino M,
Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, et al:
Redefining the relevance of established cancer cell lines to the
study of mechanisms of clinical anti-cancer drug resistance. Proc
Natl Acad Sci USA. 108:18708–18713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burdall SE, Hanby AM, Lansdown MR and
Speirs V: Breast cancer cell lines: Friend or foe? Breast Cancer
Res. 5:89–95. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cifani P, Kirik U, Waldemarson S and James
P: Molecular portrait of breast-cancer-derived cell lines reveals
poor similarity with tumors. J Proteome Res. 14:2819–2827. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manning HC, Buck JR and Cook RS: Mouse
models of breast cancer: Platforms for discovering precision
imaging diagnostics and future cancer medicine. J Nucl Med. 57
(Suppl 1):60S–68S. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo S, Qian W, Cai J, Zhang L, Wery JP and
Li QX: Molecular pathology of patient tumors, patient-derived
xenografts, and cancer cell lines. Cancer Res. 76:4619–4626. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Braekeveldt N, von Stedingk K, Fransson S,
Martinez-Monleon A, Lindgren D, Axelson H, Levander F, Willforss J,
Hansson K, Øra I, et al: Patient-derived xenograft models reveal
intratumor heterogeneity and temporal stability in neuroblastoma.
Cancer Res. 78:5958–5969. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matossian MD, Burks HE, Bowles AC, Elliott
S, Hoang VT, Sabol RA, Pashos NC, O'Donnell B, Miller KS, Wahba BM,
et al: A novel patient-derived xenograft model for claudin-low
triple-negative breast cancer. Breast Cancer Res Treat.
169:381–390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramani VC, Lemaire CA, Triboulet M, Casey
KM, Heirich K, Renier C, Vilches-Moure JG, Gupta R, Razmara AM,
Zhang H, et al: Investigating circulating tumor cells and distant
metastases in patient-derived orthotopic xenograft models of
triple-negative breast cancer. Breast Cancer Res. 21:982019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pandrangi SL, Raju Bagadi SA, Sinha NK,
Kumar M, Dada R, Lakhanpal M, Soni A, Malvia S, Simon S, Chintamani
C, et al: Establishment and characterization of two primary breast
cancer cell lines from young Indian breast cancer patients:
Mutation analysis. Cancer Cell Int. 14:142014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chakraborty G, Jain S and Kundu GC:
Osteopontin promotes vascular endothelial growth factor-dependent
breast tumor growth and angiogenesis via autocrine and paracrine
mechanisms. Cancer Res. 68:152–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhimani J, Ball K and Stebbing J:
Patient-derived xenograft models-the future of personalised cancer
treatment. Br J Cancer. 122:601–602. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okada S, Vaeteewoottacharn K and Kariya R:
Application of highly immunocompromised mice for the establishment
of patient-derived xenograft (PDX) models. Cells. 8:8892019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kessous R, Wissing MD, Laskov I, Abitbol
J, Bitharas J, Agnihotram VR, Yasmeen A, Salvador S, Lau S and
Gotlieb WH: Multiple lines of chemotherapy for patients with
high-grade ovarian cancer: Predictors for response and effect on
survival. Int J Cancer. 148:2304–2312. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hanker LC, Loibl S, Burchardi N, Pfisterer
J, Meier W, Pujade-Lauraine E, Ray-Coquard I, Sehouli J, Harter P
and du Bois A: AGO and GINECO study group: The impact of second to
sixth line therapy on survival of relapsed ovarian cancer after
primary taxane/platinum-based therapy. Ann Oncol. 23:2605–2612.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park IH, Lee KS and Ro J: Effects of
second and subsequent lines of chemotherapy for metastatic breast
cancer. Clin Breast Cancer. 15:e55–e62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shultz LD, Schweitzer PA, Christianson SW,
Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV,
Greiner DL, et al: Multiple defects in innate and adaptive
immunologic function in NOD/LtSz-scid mice. J Immunol. 154:180–191.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chijiwa T, Kawai K, Noguchi A, Sato H,
Hayashi A, Cho H, Shiozawa M, Kishida T, Morinaga S, Yokose T, et
al: Establishment of patient-derived cancer xenografts in
immunodeficient NOG mice. Int J Oncol. 47:61–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shultz LD, Goodwin N, Ishikawa F, Hosur V,
Lyons BL and Greiner DL: Human cancer growth and therapy in
immunodeficient mouse models. Cold Spring Harb Protoc.
2014:694–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brown KM, Xue A, Mittal A, Samra JS, Smith
R and Hugh TJ: Patient-derived xenograft models of colorectal
cancer in pre-clinical research: A systematic review. Oncotarget.
7:66212–66225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mosier DE, Stell KL, Gulizia RJ, Torbett
BE and Gilmore GL: Homozygous scid/scid; beige/beige mice have low
levels of spontaneous or neonatal T cell-induced B cell generation.
J Exp Med. 177:191–194. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen L, Pan X, Zhang YH, Hu X, Feng K,
Huang T and Cai YD: Primary tumor site specificity is preserved in
patient-derived tumor xenograft models. Front Genet. 10:7382019.
View Article : Google Scholar : PubMed/NCBI
|
